ReviR Therapeutics Announces Addition of Dr. Lynne E. Maquat and Dr. Brian Safina to Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced today the formation and members of its Scientific Advisory Board with the appointments of Dr. Lynne E. Maquat and Dr. Brian Safina. “We are honored to welcome Dr. Maquat and Dr. Safina to...

Click to view original post